Complement Therapeutics GmbH
PrivateLast Round
Series A
Apr 17, 2023
Total Funding Raised
$84.36M
Company Overview
Complement Therapeutics GmbH operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Series A round in April 2023.
Complement Therapeutics GmbH is a clinical-stage biotechnology company that develops novel gene therapies and diagnostic platforms for diseases mediated by the complement system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Complement Therapeutics GmbH Comparables
Compare Complement Therapeutics GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perceive Bio | 86% | |
| Oculogenex | 83% | |
| Aviceda Therapeutics | 78% |
For institutional investors. Book with your work email.
Complement Therapeutics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 17, 2023 | ||||
| Seed | Feb 23, 2022 |
For institutional investors. Book with your work email.
Complement Therapeutics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion | Series A, Seed |
| Gimv | Series A |
| Seroba Life Sciences | Series A |
| Panakès Partners | Series A |
| Cambridge Innovation Capital | Series A |
| Hadean Ventures | Series A |
| BioGeneration Ventures | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 26, 2025
Dr. Muhammad Ali Memon leaves as VP, Clinical Science and Safety to become Chief Medical Officer.
- Nov 26, 2025
Dr. Muhammad Ali Memon appointed as new Chief Medical Officer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventAug 19, 2026
Complement Therapeutics Ltd attends Clinical Trials at the Summit in Nevada on Jun 13th '26, where presented data examines the safety and tolerability of a novel subretinal gene therapy.
For institutional investors. Book with your work email.
Complement Therapeutics GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Complement Therapeutics GmbH's valuation, stock price, and market status.
Is Complement Therapeutics GmbH a public or private company?
Complement Therapeutics GmbH is a private company.
What is the current stock price of Complement Therapeutics GmbH?
Complement Therapeutics GmbH is a private company, so its shares have no public market price. Caplight tracks Complement Therapeutics GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Complement Therapeutics GmbH worth (valuation)?
Valuation information for Complement Therapeutics GmbH is not publicly available.
Can I buy Complement Therapeutics GmbH stock?
Complement Therapeutics GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Complement Therapeutics GmbH's last funding round?
Complement Therapeutics GmbH's most recent funding round was Series A on April 17, 2023.
Who are the main investors in Complement Therapeutics GmbH?
Key investors in Complement Therapeutics GmbH include Gimv.
Will Complement Therapeutics GmbH IPO soon?
No public IPO plans have been announced for Complement Therapeutics GmbH.
How can I track Complement Therapeutics GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Complement Therapeutics GmbH's shares on secondary markets.